HMGB1 and stroke disorder: Because HMGB1 impaired the reuptake and clearance of glutamate in astrocytes in response to ischemic injury, we suggest that glycyrrhizic acid can antagonize the impaired function and possibly act as a promising adjuvant therapy for stroke in the future.